Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C Morell
The Cannabinoid WIN 55,212-2 Prevents Neuroendocrine Differentiation of LNCaP Prostate Cancer Cells
Prostate Cancer and Prostatic Diseases
Cancer Research
Oncology
Urology
Related publications
Autophagy Pathway Is Required for IL-6 Induced Neuroendocrine Differentiation and Chemoresistance of Prostate Cancer LNCaP Cells
PLoS ONE
Multidisciplinary
Cannabinoid Agonist WIN-55,212-2 Partially Restores Neurogenesis in the Aged Rat Brain
Molecular Psychiatry
Psychiatry
Molecular Neuroscience
Mental Health
Molecular Biology
Cellular
WIN 55,212-2 Decreases the Reinforcing Actions of Cocaine Through CB1 Cannabinoid Receptor Stimulation
Behavioural Brain Research
Behavioral Neuroscience
Gestational Exposure to the Cannabinoid WIN 55,212-2 and Its Effect on the Innate Intestinal Immune Response
Scientific Reports
Multidisciplinary
Cannabinoid Receptor Agonist-Induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds Through Sustained Activation of ERK1/2 Leading to G1Cell Cycle Arrest
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Cannabinoid WIN-55,212-2 Mesylate Inhibits ADAMTS-4 Activity in Human Osteoarthritic Articular Chondrocytes by Inhibiting Expression of Syndecan-1
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Involvement of the CB2 Cannabinoid Receptor in Cell Growth Inhibition and G0/G1 Cell Cycle Arrest via the Cannabinoid Agonist WIN 55,212–2 in Renal Cell Carcinoma
BMC Cancer
Cancer Research
Oncology
Genetics
Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?
Frontiers in Oncology
Cancer Research
Oncology
Is HOTAIR Really Involved in Neuroendocrine Prostate Cancer Differentiation?
Epigenomics
Cancer Research
Genetics